US2006172955A1PendingUtilityA1

Antibiotic/benzoyl peroxide dispenser

Assignee: VISHNUPAD MOHANPriority: Dec 12, 2000Filed: Mar 31, 2006Published: Aug 3, 2006
Est. expiryDec 12, 2020(expired)· nominal 20-yr term from priority
A61P 43/00A61P 31/04A61P 17/10A61K 8/02A61K 8/38A61K 8/671A61K 2800/88A61K 8/60A61M 35/003A61K 8/8158A61Q 19/00A61K 33/40A61K 8/35A61K 8/34A61Q 19/04A61K 8/44A61K 8/86A61K 8/347A61Q 19/02A61K 8/8147A61K 2800/52A61K 8/676A61K 31/74A61K 8/39A61K 8/8152A61K 45/06A61K 9/06A61K 31/70A61K 8/31
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Two separate compositions, one containing an effective anti-acne treating amount of a first active ingredient and one containing a second active ingredient that is incompatible with the first active ingredient are packaged within and dispensed from a common dispenser. By packaging these two active ingredients in this manner, long shelflife and convenient dispensing and application are provided.

Claims

exact text as granted — not AI-modified
1 . An apparatus comprising: 
 a first chamber containing a first composition, the first composition comprising an effective acne-treating amount of an antibiotic;    a second chamber containing a second composition comprising a retinoid;    pump means for moving the first and second compositions out of the first and second chambers; and    one or more outlets for dispensing the first and second compositions.    
   
   
       2 . An apparatus as in  claim 1  wherein the retinoid is selected from the group consisting of retinol, retinoic acid, retinyl palmitate, retinyl propionate, retinyl acetate and synthetic retinoid mimetics.  
   
   
       3 . An apparatus as in  claim 2  wherein the antibiotic is selected from the group consisting of erythromycin, clindamycin, tetracycline, derivatives of erythromycin, clindamycin or tetracycline and pharmaceutically acceptable salts of erythromycin, clindamycin or tetracycline.  
   
   
       4 . An apparatus comprising: 
 a first chamber containing a first composition, the first composition comprising an effective acne-treating amount of benzoyl peroxide;    a second chamber containing a second composition comprising a retinoid;    pump means for moving the first and second compositions out of the first and second chambers; and    one or more outlets for dispensing the first and second compositions.    
   
   
       5 . An apparatus as in  claim 4  wherein the retinoid is selected from the group consisting of retinol, retinoic acid, retinyl palmitate, retinyl propionate, retinyl acetate and synthetic retinoid mimetics.  
   
   
       6 . A method of treating acne comprising 
 simultaneously pumping a first composition and a second composition from first and second chambers, respectively,    the first composition comprising an effective acne-treating amount of a first active ingredient selected from the group consisting of antibiotics and benzoyl peroxide,    the second composition comprising a retinoid; and    contacting the first composition and second composition with the skin of a person afflicted with acne.    
   
   
       7 . A method as in  claim 6  wherein the first active ingredient is an antibiotic.  
   
   
       8 . A method as in  claim 7  wherein the antibiotic is selected from the group consisting of erythromycin, clindamycin, tetracycline, derivatives of erythromycin, clindamycin or tetracycline and pharmaceutically acceptable salts of erythromycin, clindamycin or tetracycline.  
   
   
       9 . A method as in  claim 6  wherein the retinoid is selected from the group consisting of retinol, retinoic acid, retinyl palmitate, retinyl propionate, retinyl acetate and synthetic retinoid mimetics.  
   
   
       10 . A method as in  claim 6  wherein the first active ingredient is benzoyl peroxide.  
   
   
       11 . A method as in  claim 10  wherein benzoyl peroxide comprises from about 0.1 to about 25 weight percent of the second composition.  
   
   
       12 . A method as in  claim 6  wherein the first composition is substantially anhydrous.  
   
   
       13 . A method as in  claim 6  wherein the second composition is substantially anhydrous.

Join the waitlist — get patent alerts

Track US2006172955A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.